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constraints and setting different optimization priorities for 
the target and the bladder, rectum and sigmoid colon as 
organs at risk (OARs). The resulting plans were evaluated 
with respect to dosimetric parameters and the plan 
conformity index. The probability of controlling the tumour 
and the normal tissue complication probabilities for each OAR 
were also determined for each plan and patient, as well as 
the probability of cure without complication, P+. 
Results: The dosimetric and volumetric comparison of the 
GRO and HIPO plans in terms of D90, D98, and D2cm3 for rectum, 
bladder and the sigmoid colon rendered similar results. The 
plan conformity expressed as COIN index was also similar for 
the two plans, the average value for the GRO being 0.541, 
and for HIPO 0.595, respectively. For all GRO and HIPO 
brachytherapy plans evaluated together with the external 
beam plans the P+ values, calculated as TCP – NTCP for one of 
the OARs, bladder, rectum and sigmoid colon, at the time, 
were above 0.89. The percent variation of the average P+, 
between GRO and HIPO plans was -0.5%, 2.1% and 1.6% for 
the bladder, rectum and sigmoid, respectively. The results 
indicate that the HIPO plan was only marginally inferior to 
the GRO plan with respect to the probability of controlling 
the tumour weighted against the probability of causing 
bladder complication with a negative difference in P+ of 
0.5%, while with respect to the rectum and the sigmoid 
column the HIPO plan was slightly superior to GRO with an 
excess of P+ of 2.1% and 1.6% respectively. 
Conclusions: The HIPO approach for performing inverse 
planning in brachytherapy renders plans comparable to the 
graphically optimised ones as assessed with the use of 
radiobiological parameters sensitive to small differences in 
the dose distribution, such as the probability of cure without 
complication, P+. 
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Purpose/Objective: To retrospectively assess the incidence 
and clinical characteristics of patients with uterine 
perforation during image-guided intracavitary High-Dose-Rate 
(HDR) brachytherapy for carcinoma of the cervix. 
Materials and Methods: Patients with cervix cancer treated 
with image-guided HDR brachytherapy from February 2006 to 
December 2012 were retrospectively identified. All 
applications were performed without radiological guidance 
for uterine tandem insertion. CT images were analyzed for 
uterine perforation or near-perforation (sub-serosal insertion 
of tandem, i.e. within 5 mm from the uterine serosa). 
Patient's demographic and clinical data were collected and 
their correlation with the incidence of perforation was 
assessed by logistic regression analysis. 
Results: A total of 231 brachytherapy CT-guided applications 
for 82 patients were reviewed. We identified 34 (14.7%) 
treatment plans with sub-optimal insertion of intra-uterine 
tandem in 20 (24.4%) patients: 14 (6%) applications with 
uterine perforation and 20 (8.6%) applications with sub-
serosal insertion of tandem. Four patients (4.8%) presented 
both uterine perforation and sub-serosal insertion. 
Figure 1. Examples of uterine perforation (a) and sub-serosal 
insertion of intra-uterine tandem (b), in sagittal and coronal 
views. 
a. 
 
b. 
 
 
Although it has been noticed a correlation between patient's 
age (median 55.5 years) and advanced disease stage (IIB and 
IIIB) and the incidence of a sub-optimal insertion of intra-
uterine tandem, the logistic regression analysis showed that 
only the stage could be a predictor for a sub-optimal implant 
(p = 0.005), but not the age (p = 0.18).  
Due to limited data regarding the initial and residual tumor 
volume post EBRT, its relation to the incidence of sub-
optimal implants could not be analyzed.  
Table 1. Patient characteristics (n = 82) 
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1SD – standard deviation 
2CR – complete response 
Conclusions: CT imaging allows detection of uterine 
perforation, as well as sub-serosal insertion of uterine 
tandem in CT-guided intracavitary HDR brachytherapy for 
cervix carcinoma. We report a relatively low incidence of 
these events, even without image guidance during applicators 
insertion. 
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Purpose/Objective: In brachytherapy, cervical tumors with 
large width and laterally asymmetrical geometry are difficult 
to treat with intracavitary applicators only. Combined 
intracavitary/interstitial applicators can optimize the 
possible dose distributions. This work proposes the use of a 
commercial available applicator in a modified way for better 
tumor coverage. 
Materials and Methods: A 70-year-old patient with stage IIB 
cervical cancer was treated with 50.4 Gy in 28 fractions 
external beam whole pelvic radiotherapy, additional 
brachytherapy with a planning aim of HR CTV D90 > 90 Gy 
EQD2 and HR CTV D98 > 80 Gy EQD2 in 4 fractions. An ovoid 
with holes drilled for guiding needle insertion was used 
(Utrecht applicator, Elekta Brachytherapy). The first 
insertion was done by conventional ovoids/needles position. 
In the second insertion, one ovoid was rotated, not fixed to 
the tandem and fixation mechanics, the needles were 
inserted more laterally to improve tumor coverage. 
Results: In MRI, the HR CTV maximum width was 4.1 cm, 3.5 
cm right-sided and 0.6 cm left-sided from the tandem. HR 
CTV volume was 49 cm3. With the rotating ovoid technique, 
the position of needles at level of tumor maximum width was 
0.5 cm shifted to right lateral side. And these resulted an 
improvement of D90 dose from 7.1 to 7.7 Gy and D98 dose 
from 5.8 to 6.3 Gy while decreasing doses to bladder and 
sigmoid. 
Conclusions: The novel technique of rotating ovoid-guided 
needles insertion was feasible and resulted improvement of 
dose coverage to tumor with remarkably laterally asymmetric 
geometry, and additionally diminish doses to surrounding 
normal organs. 
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Purpose/Objective: Cervical cancer is third most common 
female cancer and the fourth most common cause of cancer 
death. Combination of external beam radiation therapy 
(EBRT) with concomitant chemotherapy (CT) and 
brachytherapy (BT) is an essential treatment modality for this 
pathology. In intracavitary (IC) BT, an applicator is placed in 
uterine cavity and vaginal fornices. The accurate positioning 
of the IC applicator is of extreme importance for delivering 
the appropriate dose to the target volume, while keeping the 
surrounding tissues and organs with doses below their 
tolerance limits. Uterine perforation can lead to under 
dosage of the target volume and excessive dosage in the 
organs at risk, compromising local control of the disease and 
increasing the risk of acute and long-term complications. 
The aim of this work is to determine the incidence and 
characteristics of uterine perforation since the introduction 
of the 3D image-guided BT and its impact on the treatment of 
patients with cervical cancer. 
Materials and Methods: It was performed a retrospective 
analysis of clinical and radiological process of patients with 
cervical cancer treated with utero-vaginal image guided BT, 
between October/2011 and October/2104. 
Results: Between October/2011 and October/2014, 163 
patients underwent utero-vaginal BT with curative intent, 
314 applications were made. In all patients the treatment 
plan included EBRT (40 to 50 Gy) with concomitant CT. 
Uterine perforation occurred in 23 patients (14.1%) and in 27 
applications (8.6%). The most common site of perforation was 
the uterine fundus, followed by the anterior and posterior 
wall. All patients were treated conservatively without 
complications. The treatment was feasible in 13 patients who 
had uterine perforation. In patients who suffered uterine 
perforation, the average diagnosis age was 55 years old (30 to 
74 years old) and the average size of the cervix at diagnosis 
was 5 cm (3 to 7 cm). Six of these patients were submitted to 
previous cone biopsy and only 5 patients had retroflexed 
uterus. 
